Final report of University Hospital Hradec Kralove to the clinical trial protocol no. CA204004

Abstract

realization of a part of clinical trial called A Phase 3, Randomized, Open Label Trial of Lenalidomide/Dexamethasone with or without Elotuzumab in relapsed or refractory Multiple Myeloma

Keywords

• lenalidomide
• dexamethasone
• elotuzumab
• refractory multiple myeloma